Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Seegene, Inc.
  6. News
  7. Summary
    A096530   KR7096530001

SEEGENE, INC.

(A096530)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Seegene Inc. Reports Earnings Results for the First Quarter of 2021

05/11/2021 | 09:18pm EDT

Seegene Inc. reported earnings results for the first quarter of 2021. The firm posted KRW 351.8 billion in consolidated revenue, a 330% increase compared to the same period last year and a record for the first quarter. Operating profit at KRW 193.9 billion, also up 388% on-year, reflecting steady growth in its sales of diagnostic tests.


ę S&P Capital IQ 2021
All news about SEEGENE, INC.
07:01aSEEGENE : Unveils Fully Automated Molecular Testing System at the 2021 AACC
AQ
09/01SEEGENE : Receives CE-IVD Mark for Use of Combo Swab, a Self-Collection Device with Four C..
AQ
08/18SEEGENE : Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY
AQ
08/18Seegene Inc. Reports Earnings Results for the Second Quarter and First Half Ended June ..
CI
07/13SEEGENE : Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Vari..
AQ
07/13Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Var..
CI
07/06SEEGENE : announces partnership with Bio-Rad to develop diagnostic testing products for th..
AQ
07/02Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on March 9, 2021.
CI
07/02Tranche Update on Seegene, Inc.'s Equity Buyback Plan announced on March 9, 2021.
CI
06/29SEEGENE : unveils "MOBILE STATION," for on-site routine testing at public-use facilities a..
AQ
More news
Financials
Sales 2021 1 244 B 1,06 B 1,06 B
Net income 2021 486 B 0,41 B 0,41 B
Net Debt 2021 - - -
P/E ratio 2021 7,02x
Yield 2021 5,75%
Capitalization 3 382 B 2 869 M 2 872 M
Capi. / Sales 2021 2,72x
Capi. / Sales 2022 4,74x
Nbr of Employees 833
Free-Float 67,9%
Chart SEEGENE, INC.
Duration : Period :
Seegene, Inc. Technical Analysis Chart | A096530 | KR7096530001 | MarketScreener
Technical analysis trends SEEGENE, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 65 300,00 KRW
Average target price 89 000,00 KRW
Spread / Average Target 36,3%
EPS Revisions
Managers and Directors
Jong-Yoon Chun Chief Executive Officer & Director
Jung-Yong Kim Director & Head-Finance
Hong-Il Yoon Independent Director
Chang-Se Lee Independent Director
Kyung-Jun Chun Director
Sector and Competitors
1st jan.Capi. (M$)
SEEGENE, INC.-32.33%2 903
EXACT SCIENCES CORPORATION-27.53%16 511
GUARDANT HEALTH, INC.-0.37%13 007
INVITAE CORPORATION-28.10%6 533
BGI GENOMICS CO., LTD.-28.50%5 827
ADAPTIVE BIOTECHNOLOGIES CORPORATION-38.29%5 137